Ryan Lynch

Insider Reports History

Reporting-owner location: Lexington, MA
Latest reporting-owner signature: /s/ Barbara Bispham, as attorney-in-fact for Ryan Lynch
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ryan Lynch

Form 4 holding Treasurer, Senior Vice President of Finance and Chief Accounting Officer.

CRESCENT BIOPHARMA, INC.

Security class: Ordinary Shares
Shares / value: 12,378
Estimated value: $186,660
Report date: 15 Dec 2025
Price: $15.08
Ownership: Direct

Form 4 holding Treasurer, Senior Vice President of Finance and Chief Accounting Officer.

CRESCENT BIOPHARMA, INC.

Security class: Stock Option (Right to Buy)
Shares / value: 33,512
Estimated value
Report date: 15 Dec 2025
Price
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount

Insider Reports Filed by Ryan Lynch

4 GLYC

CRESCENT BIOPHARMA, INC.

Report period: 15 Dec 2025
Transactions: 3
Transaction value: $0
Accepted by SEC: 17 Dec 2025, 16:38
Role: Treasurer, Senior Vice President of Finance and Chief Accounting Officer.
Next action: Open filing details

3 GLYC

GLYCOMIMETICS INC

Report period: 13 Jun 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 23 Jun 2025, 18:29
Role: Treasurer, Senior Vice President of Finance and Chief Accounting Officer. Exhibit 24 - Power of Attorney
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .